PW Medtech Advances with Sichuan Ruijian Spin-Off Plans

PW Medtech Group Ltd. (HK:1358) has released an update.

PW Medtech Group Ltd. has announced the successful completion of the NEEQS Quotation for its subsidiary, Sichuan Ruijian Medical, as part of a proposed spin-off. The company is considering a Subsequent Listing for Sichuan Ruijian Medical, which could impact its status as a subsidiary. Investors are advised to stay cautious, as the listing depends on market conditions and regulatory approvals.

For further insights into HK:1358 stock, check out TipRanks’ Stock Analysis page.